Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 11, 1999

View Archived Issues

Novo Nordisk, Takeda will collaborate on marketing of antidiabetic drugs in Japan

Novel benzoxazine compounds for treating neurological and psychological disorders

Novel NSAIDs synthesized and evaluated at Ortho-McNeil

Structurally unique metabotropic glutamate receptor ligands disclosed by Pfizer

Inflazyme: Q2 1999 highlights

Bone Care gears up for launch of first product during Q4 1999

Licensing opportunity from NIH: NAT modulators for enhancing efficacy, reducing toxicity of drugs

Bayer submits amendment to ProMem NDA

Advanced Magnetics receives NIH grant to support research into new diagnostic approach

Argonex forms gene therapy joint venture with Rohm and Haas

PD-184352 inhibits growth of colon tumors in mice via interference with MAPK pathway

Visudyne filed for marketing approval with EMEA

PRAISE study will evaluate Merck drug's ability to prevent AD in patients with mild memory loss

Limonene analogue XR-3054 is a novel protein farnesyltransferase inhibitor

Ethical, LEK to collaborate on development of transdermal analgesic

Third-generation lentiviral vectors from Cell Genesys boast improved safety features

Protein farnesyltransferase inhibitors from Pfizer inhibit abnormal cell growth

New antifungal agents from SS Pharm. with more potent activity than fluconazole

Antiallergic quinoline compounds prepared and tested by Dainippon Ink & Chemicals

FDA further expands approved indications for Zocor

BioSpecifics Technologies announces positive preliminary results in Peyronie's disease therapy

Cytarabine analogue P-4055 has significantly higher antitumor potency; clinical trials recommended

Antiparkinsonian potential of 968, an active compound extracted from Chinese herbs

Phase II oral mucositis results promising; nonetheless, P&U withdraws from IB-367 collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...